🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Skin Condition

DANIsh VASculitis Database (DANIVAS) NCT05935709n/a2 sites📍 Aarhus📍 Horsens Aarhus University Hospital A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic Repair NCT07734584NA4 sites📍 Bologna📍 Brescia📍 Genova University of Bologna · Tests: Carbon dioxide pre-implant endograft flushing followed by saline flushing, Saline endograft flushing A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438Phase 28 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Stereotactic body radiotherapy Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Hospital at Home for Elderly Acute Ill Patients NCT05360914NA3 sites📍 Silkeborg📍 Skive📍 Viborg Defactum, Central Denmark Region · Tests: Hospital at Home (HaH) treatment, Standard hospital admission The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children NCT05758532Phase 41 site📍 Geneva Laure Pittet, MD-PhD · Tests: Measles-Mumps-Rubella vaccine (MMR) Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-1801 CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry NCT06238765n/a1 site📍 Waltham CorEvitas A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. NCT07062965Phase 3433 sites📍 Anchorage📍 Chandler📍 Gilbert Pfizer · Tests: PF-07248144, Fulvestrant, Everolimus, Exemestane ETHAN - ET for Male BC NCT05501704Phase 29 sites📍 Washington D.C.📍 Jacksonville📍 Boston Jose Pablo Leone · Tests: Tamoxifen, Anastrozole, Degarelix, Abemaciclib COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY NCT07102836Phase 21 site📍 Bahawalpur Quaid-e-Azam Medical College · Tests: Zinc sulfate, Probiotic lactobacillus rhamnosus GG Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers NCT07158658NA2 sites📍 Bossier City📍 Rayville NuScience Medical Biologics, LLC · Tests: NeoThelium FT (HCT/P 361) Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata NCT06747611Phase 21 site📍 Minneapolis University of Minnesota · Tests: Vancomycin, Neomycin and MTT capsules, Placebo capsules An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma NCT06008106Phase 31 site📍 Beijing Shanghai Kechow Pharma, Inc. · Tests: tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin Intravenous Versus Oral Treatment of the Main Acute Infections NCT06715306NA7 sites📍 Aabenraa📍 Copenhagen📍 Copenhagen University of Southern Denmark · Tests: Oral treatment Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma NCT06606028n/a1 site📍 San Francisco University of California, San Francisco · Tests: Blood Specimen Collection, Tumor Tissue Collection, Medical Record Review PREgnancy and FERtility Registry NCT02895165n/a23 sites📍 Asti📍 Brindisi📍 Monserrato IRCCS Azienda Ospedaliera Universitaria San Martino - IST I… Twenty-four Hour Movement Behaviors and Atherosclerotic Risk NCT07774507n/a1 site📍 Presidente Prudente São Paulo State University Evaluation of Hypoxia in Primary Melanoma NCT06831071n/a1 site📍 Pittsburgh Yana Najjar · Tests: Pimonidazole Naltrexone and Propranolol Combined With Immunotherapy NCT05968690Phase 11 site📍 New Brunswick Sarah Weiss · Tests: Propranolol, Naltrexone A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites📍 Syracuse📍 Charleston Medical University of South Carolina · Tests: Carboplatin, Paclitaxcel, Pembrolizumab CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site📍 Shanghai RenJi Hospital · Tests: GILUPI CellCollector® Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer NCT05377047Phase 319 sites📍 Cork📍 Cork📍 Dublin Vastra Gotaland Region · Tests: SABR BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse NCT06643585Phase 31 site📍 Ulm Prof. Wolfgang Janni · Tests: Trastuzumab-Deruxtecan, Physicians Choice (PhC).
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy